Improving HPV vaccination rates among Latino adolescents in health centers
Official title: Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
Run by The University of Texas Health Science Center, Houston · NCT06598475 · Data updated 2026-11-12
This study is testing new ways to help healthcare providers encourage Latino teens to get the HPV vaccine in health centers that serve their communities.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 11 Years to 17 Years |
| Sex | All |
| Enrollment | 225 (estimated) |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | March 13, 2025 |
| Main results expected | February 1, 2028 |
| Study ends | August 1, 2028 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT06598475 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adolescents aged 11-17 who are patients at FQHCs with a predominantly Latino patient population and low HPV vaccination rates.
✕Probably not a fit
Patients who are not part of the Latino demographic or those who are not seeking care at participating FQHCs may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance HPV vaccination rates among Latino adolescents by implementing facilitator-driven strategies in Federally Qualified Health Centers (FQHCs). It will assess the characteristics of providers and practices that influence the effectiveness of these strategies. The study will involve training healthcare providers and staff, measuring outcomes, and evaluating the sustainability of the implementation across nine clinical sites. The focus is on increasing provider recommendations for HPV vaccinations in practices with low initiation rates.
Why it matters
Potential benefit: If successful, this study could significantly increase HPV vaccination rates among Latino adolescents, leading to better health outcomes and reduced incidence of HPV-related diseases.
How similar studies have gone: Other studies have shown success with similar facilitator-driven approaches to improve vaccination rates, indicating potential for positive outcomes in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * FQHC's with less than 60% HPV vaccine initiation rate for 11-12 year old adolescents overall at their practice sites * FQHC's that have family medicine and/or pediatric practices * a total adolescent patient population at least 50% Latino * be willing for Health Care Provider (HCP) and staff members to receive education, training, and support; complete standardized measurement, and agree to randomization. * Providers, aged 18 and over, employed at each FQHC (4 staff per practice) * Staff, aged 18 and over, employed at each FQHC (5 staff per practice) * Implementation team members (i.e., administrative designee, health care providers, immunization navigators, and other staff), aged 18 and over, employed at each FQHC (4 members per practice) * Parents (aged 18 and over) of patients ages 11-17 seeking care at each FQHC (25 per practice). Exclusion Criteria: -FQHCs that participated in the pilot study were excluded.
Where it's running
-
The University of Texas Health Science Center at Houston
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Daisy Y Morales Campos, PhD — The University of Texas Health Science Center, Houston
- Study coordinator: Daisy Y Morales-Campos, PhD
- Email: Daisy.Y.MoralesCampos@uth.tmc.edu
- Phone: (210) 276 9042
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lived experiences of women with HPV infection
This study talks with women who have HPV to hear in their own words how the infection affects daily life, relationships, and what information or support they wish they had.
-
Same-day HPV self-testing with digital cytology triage in Cameroon
This project will test whether HPV self-sampling followed by same-day digital telecytology can quickly find which HPV-positive women aged 30–49 (25–49 if HIV-positive) in Cameroon need treatment.
-
Point-of-care triage and thermal treatment for cervical precancer with the IRIS device
This project tests a portable thermal ablation device plus an AI image triage tool to treat and prioritize HPV-positive women aged 30–49 with cervical precancer in El Salvador.
-
Self-collected HPV testing to help prevent cervical cancer
This trial tests whether people referred for colposcopy can collect their own vaginal sample for HPV testing and whether those self-samples match clinician-collected cervical samples.
-
Using liquid biopsies to monitor treatment in HPV-related cancers
This study tests if using liquid biopsies can help track treatment progress and detect any return of HPV-related cancers, like cervical and throat cancer, in patients.
-
Self-sampling to improve cervical cancer screening attendance
This study is testing if sending self-sampling kits by mail, through gynecologists, or general practitioners can help more women in the Czech Republic get screened for cervical cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.